Metoprolol Succinate Tablet, Film Coated, Extended Release
Product Images NDC 71205-368

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Metoprolol Succinate (NDC 71205-368). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

1 (Image 1)

The image shows a white rectangular container with slightly rounded edges, possibly a blister card or tablet holder for metoprolol succinate extended-release film-coated tablets. The surface appears plain with no visible text or markings on the visible side.*

FDA Label Image

71205-368-30 (Image 11)

Label for metoprolol succinate 25 mg extended release (ER) film-coated tablets, packaged in a quantity of 30. The label shows the product name, strength, dosage form, and details including that each film-coated tablet contains 23.75 mg metoprolol succinate (USP equivalent to 25 mg metoprolol tartrate). The product is labeled by Proficient Rx LP and mentions manufacturer Teva Pharmaceuticals USA. Additional information includes storage instructions and safety warnings.*

FDA Label Image

1 (Image 2)

Metoprolol succinate 25 mg extended-release film-coated tablets in a carton packaging. The front label displays the proprietary and generic names, dosage strength, dosage form, and route of administration as oral tablets. The product is labeled by Proficient Rx LP with the NDC 71205-368.*

FDA Label Image

1 (Image 3)

Metoprolol succinate 25 mg extended release film-coated tablets in an oral dosage form. The image shows a white bottle with a child-resistant cap. The printed label displays the Proficient Rx LP logo and includes drug name, strength, dosage form, and other regulatory information.*

FDA Label Image

1 (Image 4)

The image shows the packaging label for metoprolol succinate 25 mg extended-release film-coated tablets. It includes branding from Proficient Rx LP and indicates an oral dosage form. The label design uses a white and blue color scheme with text specifying the drug name and strength.*

FDA Label Image

2 (Image 5)

Chemical structure diagram of metoprolol succinate showing the molecular arrangement with labeled atoms and bonds presented in black and white.*

FDA Label Image

1 (Image 6)

A forest plot chart presenting results for subgroups in the MERIT-HF study. It shows relative risk and 95% confidence intervals for total mortality, total mortality or all-cause hospitalization, and total mortality hospitalization for heart failure, comparing metoprolol succinate extended-release versus placebo across various subgroups (e.g., US vs non-US, NYHA classes, ejection fraction ranges, sex, race, history of myocardial infarction, diabetes, hypertension, and heart rate groups). Each plot indicates favoring either metoprolol succinate extended-release or placebo.*

FDA Label Image

1 (Image 7)

The image shows a carton for metoprolol succinate 25 mg film-coated extended-release tablets. The packaging indicates it contains oral tablets and is labeled by Proficient Rx LP. The NDC provided is 71205-368. The design is primarily simple with the product name prominently displayed.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.